...
首页> 外文期刊>Molecular pharmaceutics >An investigation into the role of polymeric carriers on crystal growth within amorphous solid dispersion systems.
【24h】

An investigation into the role of polymeric carriers on crystal growth within amorphous solid dispersion systems.

机译:研究聚合物载体在无定形固体分散体系中对晶体生长的作用。

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

Using phase diagrams derived from Flory-Huggins theory, we defined the thermodynamic state of amorphous felodipine within three different polymeric carriers. Variation in the solubility and miscibility of felodipine within different polymeric materials (using F-H theory) has been identified and used to select the most suitable polymeric carriers for the production of amorphous drug-polymer solid dispersions. With this information, amorphous felodipine solid dispersions were manufactured using three different polymeric materials (HPMCAS-HF, Soluplus, and PVPK15) at predefined drug loadings, and the crystal growth rates of felodipine from these solid dispersions were investigated. Crystallization of amorphous felodipine was studied using Raman spectral imaging and polarized light microscopy. Using this data, we examined the correlation among several characteristics of solid dispersions to the crystal growth rate of felodipine. An exponential relationship was found to exist between drug loading and crystal growth rate. Moreover, crystal growth within all selected amorphous drug-polymer solid dispersion systems were viscosity dependent (η(-ξ)). The exponent, ξ, was estimated to be 1.36 at a temperature of 80 °C. Values of ξ exceeding 1 may indicate strong viscosity dependent crystal growth in the amorphous drug-polymer solid dispersion systems. We argue that the elevated exponent value (ξ > 1) is a result of drug-polymer mixing which leads to a less fragile amorphous drug-polymer solid dispersion system. All systems investigated displayed an upper critical solution temperature, and the solid-liquid boundary was always higher than the spinodal decomposition curve. Furthermore, for PVP-FD amorphous dispersions at drug loadings exceeding 0.6 volume ratio, the mechanism of phase separation within the metastable zone was found to be driven by nucleation and growth rather than liquid-liquid separation.
机译:使用从Flory-Huggins理论得到的相图,我们定义了三种不同聚合物载体中非晶形非洛地平的热力学状态。非洛地平在不同聚合物材料中的溶解度和可混溶性的变化(使用F-H理论)已经确定,并用于选择最合适的聚合物载体来生产无定形药物-聚合物固体分散体。有了这些信息,就可以使用三种不同的聚合材料(HPMCAS-HF,Soluplus和PVPK15)以预定的药物负载量生产非晶形非洛地平固体分散体,并研究了这些固体分散体中非洛地平的晶体生长速率。使用拉曼光谱成像和偏振光显微镜研究了非晶态非洛地平的结晶。使用该数据,我们检查了固体分散体的若干特征与非洛地平晶体生长速率之间的相关性。发现载药量和晶体生长速率之间存在指数关系。此外,在所有选定的无定形药物-聚合物固体分散体系中的晶体生长均取决于粘度(η(-ξ))。在80°C的温度下,指数ξ估计为1.36。 ξ的值超过1可能表示在非晶态药物-聚合物固体分散体系统中,强烈的粘度依赖性晶体生长。我们认为升高的指数值(ξ> 1)是药物-聚合物混合的结果,这导致较不易碎的非晶态药物-聚合物固体分散体系。所有研究的系统均显示出较高的临界溶液温度,并且固液边界始终高于旋节线分解曲线。此外,对于载药量超过0.6体积比的PVP-FD无定形分散体,发现亚稳区内的相分离机制是由成核和生长驱动的,而不是由液-液分离驱动的。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号